Idiopathic Or Diabetic Gastroparesis clinical trials

Explore recruiting idiopathic or diabetic gastroparesis clinical trials.

Recruiting idiopathic or diabetic gastroparesis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Idiopathic Or Diabetic Gastroparesis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Double-blind, randomised, placebo-controlled, dose-finding phase IIb trial to evaluate the efficacy, safety, and tolerability of a 12-week-treatment with Naronapride in adult participants with at least moderate idiopathic or diabetic gastroparesis

Italy, Austria, Belgium, Netherlands, Germany, Poland +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 1 multi-centre, randomized, single-blind, steady-state study to evaluate pharmacokinetics, pharmacodynamics, safety and tolerability after multiple-dose administration of three different doses of naronapride in patients with moderate idiopathic or diabetic gastroparesis compared to healthy subjects

Germany, Belgium, Poland

Human Pharmacology (Phase I)- Other EU CTIS Study details

A MULTICENTER OPEN LABEL 3 MONTH SAFETY STUDY WITH TRADIPITANT IN PATIENTS WITH IDIOPATHIC OR DIABETIC GASTROPARESIS

Belgium, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Idiopathic Or Diabetic Gastroparesis trials by city